Navigation Links
WomanCare Global Acquires 2 Global Brands From ICON -- Combined Oral Contraceptive Roselle® and Emergency Contraceptive Optinor®
Date:10/26/2010

CHAPEL HILL, N.C., Oct. 26 /PRNewswire/ -- WomanCare Global is pleased to announce an expansion of their global product portfolio to include Roselle®, a combined oral contraceptive (COC) pill composed of 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol and Optinor®, a progesterone-only emergency contraception pill (ECP) composed of 750 micrograms of levonorgestrel.

(Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101018/DC83896LOGO)

Both products were developed by ICON in partnership with a trusted generic manufacturer following an extensive in-depth quality and technical assessment process undertaken by qualified experts in 2005.  Both formulations are included in the WHO Interagency List of Essential Medicines for Reproductive Health.  ICON is the International Planned Parenthood Federation (IPPF) subsidiary responsible for commodity supply to IPPF member associations.  

With this acquisition, WomanCare Global has global rights to Roselle® and Optinor® and a partner in making these branded products available to IPPF's global network of Member Associations located in over 170 countries.  WomanCare Global will also market these products to other public and private sector markets around the world using their established global supply chain and logistics network.  

"This partnership with WomanCare Global is a significant step forward in expanding access to quality assured generic hormonal contraceptives at competitive prices," said ICON's General Manager, David Smith.

"WomanCare Global is excited about this important strategic alliance with a key partner," said WCG Chief Operating Officer Saundra Pelletier. "The addition of these 2 new products to our global portfolio will make a significant difference to women around the world who deserve access to high-quality and affordable products.  Roselle® and Optinor® will become important options for women."

About WomanCare Global

WomanCare Global provides access to high-quality, innovative and affordable reproductive healthcare technologies for contraception, fertility and pregnancy management.  WomanCare Global's mission is to expand the availability of these technologies in both public and private sectors via an established global supply chain reaching over 80 countries, with particular focus on under-served markets in Africa, Asia and Latin America. WomanCare Global is a hybrid business model, combining the best practices of for-profit and not-for-profit entities.  WomanCare Global has regulatory and quality departments that assure adherence to regulatory requirements and global quality standards in addition to a comprehensive global sales, marketing, and distribution channel. For more information about WomanCare Global, visit www.womancareglobal.com


'/>"/>
SOURCE WomanCare Global
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
2. Decision Resources Forecast of Global Tanezumab Sales Slashed Following FDA Halt of Phase III Studies
3. Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors
4. Merlot OrthopediX Enters into Exclusive Global Agreement with Alphatec Spine to Develop and Market Merlots Bone Anchorage Technology for the Treatment of Spine Disorders
5. Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics
6. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
7. Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis
8. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
9. Reportlinker Adds Global Minimally Invasive Surgery Market.(2010 - 2015)
10. Reportlinker Adds Global Diagnostic ECG Market (2010 - 2015)
11. Reportlinker Adds Global Wound Care Products Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):